EPA, Guiding treatment decisions for improved clinical results and cost effective care

Introduction – Dr.S.Läuchli

Guiding treatment decisions for improved clinical results and cost effective care.

Talk 1 – Dr.R.Anichini

Testing for elevated protease activity and targeting treatment in clinical practice.

Talk 2 – Dr.C.Dowsett

The economic implications of implementing a ‘test and treat’ approach to care.

Talk 3 – Prof.F.Duteille

EPA, a predictor of skin graft failure.Implications for standard practice.